🔖
Cite This Article
GÖZDAŞOĞLU, S. (2022). Kasabach-Merritt Syndrome in an Adult: A Comment. Turkish Journal of Hematology, Cilt: 36 - Sayı: 1, 52–52. https://ajindex.com/articles/606654
Journals / Turkish Journal of Hematology / 2019 / Cilt: 36 - Sayı: 1
Kasabach-Merritt Syndrome in an Adult: A Comment
- Pages
- 52–52
- Publication Date
- 2022-11-04
- DOI
- —
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗References (7)
- Vinod KV, Johny J, Vadivelan M, Hamide A. Kasabach-Merritt syndrome in an adult. Turk J Hematol 2018;35:204-205
- Özsoylu Ş. Megadose methyl-prednisolone (MDMP) for hemangiomatosis. Turk J Hematol 2012;29:436-437
- Özsoylu Ş. About the treatment of Kasabach-Merritt syndrome. Turk J Hematol 2013;30:94
- Uysal KM, Olgun N, Erbay A, Sarıalioğlu F. High-dose oral methylprednisolone therapy in childhood hemangiomas. Pediatr Hematol Oncol 2001;18:335- 341
- Gözdaşoğlu S, Uysal Z, Ertem M, Suskan E, Kürekci E, İleri T, Azık F, Cin Ş. Bebeklik çağı Hemanjiomlarında interferon - α 2a tedavisi. In: IV. Ulusal Pediatrik Hematoloji Kongresi, 10-13 September Trabzon, Turkey, 2003
- Mahajan D, Miller C, Hirose K, McCullough A, Yerian L. Incidental reduction in the size of liver hemangioma following use of VEGF inhibitor bevacizumab. J Hepatol 2008;49:867-870
- Kahana A, Lee BJ, Flint A, Elner VM. Periocular epithelioid hemangioma: response to bevacizumab and vascular pathogenesis. JAMA Ophthal 2012;130:1209-1212.